MORE THAN IMMUNOTHERAPY
'IO, IO,' to ASCO we go: Data parade getting less abstract for Wall Street
By Randy Osborne
Thursday, May 15, 2014
With eagerly awaited abstracts unleashed on the world from the American Society of Clinical Oncology (ASCO) annual meeting, pundits and investors were ransacking the batch for clues to success. ASCO unveiled no fewer than 5,000 studies from which results were to be offered at the cancer meeting, which starts in about two weeks.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.